Phase II trial of cetuximab plus docetaxel in patients with relapsed head and neck carcinoma

被引：0
|
作者：
Knoedler, M. [1 ]
Na, I. -K. [1 ]
Rohde, M. [1 ]
Thiel, E. [1 ]
Schmittel, A. [1 ]
Keilholz, U. [1 ]
机构：
[1] Charite Med Klin III, Berlin, Germany
来源：
ONKOLOGIE | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [1] Phase II trial to evaluate efficacy and toxicity of cetuximab plus docetaxel in platinum pretreated patients with recurrent and/or metastatic head and neck cancer
    Knoedler, M.
    Gauler, T. C.
    Matzdorff, A.
    Dietz, A.
    Gruenwald, V.
    Arnold, D.
    Hennemann, B.
    Schroeder, M.
    Hofele, C.
    Schmittel, A.
    Keilholz, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck
    Glisson, BS
    Murphy, BA
    Frenette, G
    Khuri, FR
    Forastiere, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1593 - 1599
  • [3] Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma - A phase II trial
    Baur, M
    Kienzer, HR
    Schweiger, J
    DeSantis, M
    Gerber, E
    Pont, J
    Hudec, M
    Schratter-Sehn, AU
    Wicke, W
    Dittrich, C
    CANCER, 2002, 94 (11) : 2953 - 2958
  • [4] A multicenter phase II trial of docetaxel, cisplatin and cetuximab (TPE) followed by cetuximab concurrent with radiotherapy in patients with local advanced squamous cell carcinoma of the head and neck (ECRIPS study).
    Zenda, Sadamoto
    Ota, Yosuke
    Kiyota, Naomi
    Okano, Susumu
    Fujii, Masato
    Kitamura, Morimasa
    Takahashi, Shunji
    Ueda, Tsutomu
    Monden, Nobuya
    Yamanaka, Takeharu
    Tahara, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] A phase II trial of docetaxel plus cisplatin in recurrent and/or metastatic non-squamous cell carcinoma of head and neck
    Imamura, Y.
    Kiyota, N.
    Tanaka, K.
    Hayashi, H.
    Ota, I.
    Nario, K.
    Hirano, S.
    Arai, A.
    Iwae, S.
    Onoe, T.
    Minami, S.
    Shimada, T.
    Yane, K.
    Yamazaki, T.
    Nagatani, Y.
    Toyoda, M.
    Otsuki, N.
    Nibu, K-I.
    Minami, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
    Bhatia, Aarti
    Mehra, Ranee
    Bauman, Jessica
    Khan, Saad A.
    Wei, Wei
    Neumeister, Veronique
    Sandoval-Schaefer, Teresa
    Alpaugh, R. Katherine
    Lango, Miriam
    Rimm, David L.
    Ridge, John A.
    Burtness, Barbara
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025,
  • [7] A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Kochanny, Sara E.
    Worden, Francis P.
    Adkins, Douglas R.
    Lim, Dean W.
    Bauman, Julie E.
    Wagner, Stephanie A.
    Brisson, Ryan J.
    Karrison, Theodore G.
    Stadler, Walter M.
    Vokes, Everett E.
    Seiwert, Tanguy Y.
    CANCER, 2020, 126 (10) : 2146 - 2152
  • [8] A randomized phase II trial of the MET inhibitor tivantinib plus cetuximab versus cetuximab alone in patients with recurrent/metastatic head and neck cancer
    Vokes, Everett E.
    Worden, Francis P.
    Adkins, Douglas
    Bauman, Julie E.
    Lim, Dean
    Sukari, Ammar
    Rao, Krishna A.
    Wagner, Stephanie Ann
    Curtis, Kelly Kevelin
    Gitlitz, Barbara J.
    Price, Katharine Andress Rowe
    Wade, James Lloyd
    Villaflor, Victoria Meucci
    De Souza, Jonas A.
    Karrison, Theodore
    Stadler, Walter Michael
    Seiwert, Tanguy Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial
    Gulati, Shuchi
    Crist, McKenzie
    Riaz, Muhammed Kashif
    Takiar, Vinita
    Lehn, Maria
    Monroe, Ilaina
    Palackdharry, Sarah
    Kurtzweil, Nicky
    Jandarov, Roman
    Harun, Nusrat
    Wise-Draper, Trisha M.
    CLINICAL CANCER RESEARCH, 2023, 29 (10) : 1906 - 1915
  • [10] Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck
    Gilbert, Jill
    Cmelak, Anthony
    Shyr, Yu
    Netterville, James
    Burkey, Brian B.
    Sinard, Robert J.
    Yarbrough, Wendall G.
    Chung, Christine H.
    Aulino, Joseph M.
    Murphy, Barbara A.
    CANCER, 2008, 113 (01) : 186 - 192
12345